Used as a protected amine intermediate in the synthesis of pharmaceutical compounds, featuring a tert-butyl carbamate (Boc) group. Particularly employed in the development of kinase inhibitors for cancer treatment, where its 4-(3,5-difluorophenyl)tetrahydro-2H-pyran scaffold supports selective binding to enzyme active sites in final drug candidates, enhancing efficacy, metabolic stability, and bioavailability. The Boc protecting group facilitates multi-step medicinal chemistry syntheses by allowing deprotection under mild acidic conditions, enabling easy reaction control and minimizing unwanted side products. Also utilized in research to construct complex molecules and improve water solubility of certain precursors under specific conditions.